NEW YORK, Nov. 30, 2006 (PRIME NEWSWIRE) -- Parker & Waichman, LLP (www.yourlawyer.com) announced that it strongly supports U.S. District Judge James Rosenbaum's decision denying Medtronic Inc.'s (NYSE:MDT) motion to dismiss hundreds of product liability cases relating to the company's recalled implantable cardioverter defibrillators (ICD's). The ruling, which was issued on Tuesday in U.S. District Court in Minneapolis, MN, means that thousands of patients and their families, who have suffered as a result of these recalled devices, will have the right to seek compensation. Parker & Waichman, LLP currently represents hundreds of victims of defective defibrillators, and the firm continues to evaluate new cases.
Patients who received defective Medtronic devices can request a free case evaluation by visiting http://www.medtronicdefectlawsuit.com or http://www.yourlawyer.com/topics/overview/medtronic_defibrillators . Case evaluations are also available by calling Parker & Waichman, LLP at 1-800-LAW-INFO (1-800-529-4636).
In February 2005, Medtronic, Inc. announced the recall of several models of implantable cardioverter defibrillators because of battery defects that could cause the devices to fail and result in serious injury or death. The battery problem affected Medtronic's Marquis line, which includes the brand names Marquis, Maximo and InSynch. It is estimated that as many as 87,000 of these devices were implanted in patients before 2003.
Medtronic notified recipients of the following defibrillator models about potential defects:
-- Micro Jewel II Model 7223Cx -- GEM DR Model 7271 implanted cardioverter-defibrillators -- 7230 Marquis VR -- 7274 Marquis DR -- 7232 Maximo VR -- 7278 Maximo DR -- 7277 InSync Marquis -- 7289 InSync II Marquis -- 7279 InSync III Marquis
In April 2004, Medtronic recalled two other heart defibrillators after they were linked to at least four deaths and one injury. This recall involved the Medtronic Micro Jewel II Model 7223Cx, and the Medtronic GEM DR Model 7271 implanted cardioverter-defibrillators. At the time, Medtronic said that most of these devices were implanted in 1997 and 1998. About 1,800 of these devices are thought to still be in use today.
About Parker & Waichman, LLP
Parker & Waichman, LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker & Waichman, LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective medical devices and medications. The firm is currently representing individuals injured by Guidant Defibrillators, Drug Coated Coronary Stents, Vioxx, Zyprexa, Ketek, ReNu with MoistureLoc, Ortho Evra and many other defective drugs and medical products. For more information on Parker & Waichman, LLP, please visit: www.yourlawyer.com or call (800) LAW-INFO.